Hjem › Parkinsons sykdom › North Carolina
Kliniske studier for Parkinsons sykdom i North Carolina
14 studier for Parkinsons sykdom søker deltakere på steder i North Carolina.
Byer i North Carolina
Offisiell studietekst (engelsk)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- University of North Carolina - Chapel Hill, Chapel Hill
RekruttererFase 2
Alder 40 til 80 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06680830A Study of Buntanetap in Participants With PD
- Duke Department of Neurosurgery, Durham
RekruttererFase 2/3
Alder 40 til 85 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07284784Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Wake Forest University School of Medicine, Winston-Salem
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT02071134A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #067, Raleigh
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Asheville Neurology Specialists, P.A. (Site #229), Asheville
- Duke Neurological Disorders Clinic (Site #210), Durham
RekruttererFase 2
Alder 30 til 80 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- University of North Carolina - Chapel Hill, Chapel Hill
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT04994015Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- Wake Forest University School of Medicine, Winston-Salem
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT03664609A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Asheville Neurology, Asheville
- Duke University Medical Center, Durham
RekruttererFase 3
Alder 50 til 85 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07174310A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Duke Neurological Disorders Clinic, Durham
RekruttererFase 3
Alder 45 til 75 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06944522Apathy in Parkinson Disease TMS Study
- UNC-Chapel Hill, Cassidy Lab, Chapel Hill
Rekrutterer
Alder 55 til 80 · Alle kjønn · Oppdatert 8. jul. 2026 · NCT06087926Targeted Motor Learning to Improve Gait for Individuals With Parkinson Disease
- University of North Carolina at Chapel Hill, Chapel Hill
Rekrutterer
Alder 50 til 80 · Alle kjønn · Oppdatert 25. jun. 2026 · NCT05864157Use of CereGate Therapy for Freezing of Gait in PD
- Wake Forest University, Winston-Salem
Rekrutterer
Alder 21 til 80 · Alle kjønn · Oppdatert 28. mai 2026 · NCT05292794Retinal Imaging in Neurodegenerative Disease
- Duke University Medical Center, Durham
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 4. feb. 2026 · NCT03233646A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Atrium Health Wake Forest Baptist Adult Neurology - Janeway Tower, Winston-Salem
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2025 · NCT06765668Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.